Is Onconetix, Inc. (ONCO) Halal?
Shariah Screening — 5 Standards
Based on financial data from December 2025
| Standard | Debt Ratio | Cash Ratio | Receivables | Income | Status |
|---|---|---|---|---|---|
| AAOIFI | 1245.0% / 30% | 85.2% / 30% | 12.7% / 30% | 0.0% / 5% | ✗ NOT HALAL |
| DJIM | 1245.0% / 33% | 85.2% / 33% | 12.7% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| MSCI | 33.5% / 33% | 2.3% / 33% | 0.3% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| S&P | 1245.0% / 33% | 85.2% / 33% | 12.7% / 33% | 0.0% / 5% | ✗ NOT HALAL |
| FTSE | 33.5% / 33% | 2.3% / 33% | 0.3% / 50% | 0.0% / 5% | ✗ NOT HALAL |
Financial Highlights
Profitability
| Gross Margin | 77.6% | |
| Operating Margin | -422.1% | |
| Net Margin | 0.0% | |
| Return on Equity (ROE) | -115.5% | |
| Return on Assets (ROA) | -14.9% |
Cash Flow & Balance Sheet
| Operating Cash Flow | -$10M |
| Free Cash Flow | -$10M |
| Total Debt | $48,774 |
| Debt-to-Equity | 0.3 |
| Current Ratio | 0.7 |
| Total Assets | $25M |
Price & Trading
| Last Close | $3.22 |
| 50-Day MA | $4.80 |
| 200-Day MA | $12.87 |
| Avg Volume | 337K |
| Beta | 3.5 |
|
52-Week Range
$1.78
| |
About Onconetix, Inc. (ONCO)
Onconetix, Inc., a biotechnology company, focuses on the research, development, and commercialization of solutions for men's health and oncology in the United States, the European Union, and Non-European Union. The company offers Proclarix, an in vitro protein-based blood diagnostic test for prostate cancer. It has a license agreement with LabCorp to develop and commercialize Proclarix and other products; and with Immunovia AB for the development, manufacturing, and commercialization of the PancreaSure test. The company was formerly known as Blue Water Biotech, Inc. and changed its name to Onconetix, Inc. in December 2023. Onconetix, Inc. was founded in 2018 and is headquartered in Cincinnati, Ohio.
Related Halal Stocks in Healthcare
Frequently Asked Questions
Is Onconetix, Inc. (ONCO) halal to invest in?
Based on our screening using AAOIFI Standard 21 (the strictest methodology), Onconetix, Inc. is Not Halal. The company fails one or more screening criteria. We screen against all 5 major standards: AAOIFI, DJIM, MSCI, S&P, and FTSE.
What is Onconetix, Inc.'s debt ratio?
Onconetix, Inc.'s debt ratio is 1245.0% under the AAOIFI standard (which uses market capitalization as the denominator). The AAOIFI threshold is 30%. Under MSCI and FTSE (which use total assets as the denominator), the debt ratio is 33.5%.
What are Onconetix, Inc.'s key financial metrics?
Onconetix, Inc. has a market capitalization of $1M, and revenue of $815,371. Return on equity stands at -115.5%.
How often is the screening data updated?
Our screening data is updated regularly using the latest available financial statements and market data. Stock prices and market caps are refreshed frequently, while financial statements are updated quarterly when companies report earnings.
Disclaimer: HalalStockGuide.com provides Shariah compliance screening for educational and informational purposes only. This is not a fatwa, financial advice, or a recommendation to buy or sell any security. Screening results are based on publicly available financial data and established methodologies. Always consult a qualified Islamic scholar and a licensed financial advisor before making investment decisions.